€37m investment won't be the last in Cork, Robert Baffi of BioMarin says

Robert Baffi, of BioMarin, tells Pádraig Hoare that the Californian rare-disease drugs firm will invest €37m in its large site at Shanbally, in Cork, with employee numbers to hit 400 by 2020

€37m investment won't be the last in Cork, Robert Baffi of BioMarin says

Robert Baffi, of BioMarin, tells Pádraig Hoare that the Californian rare-disease drugs firm will invest €37m in its large site at Shanbally, in Cork, with employee numbers to hit 400 by 2020

With the tech revolution shining a light on Cork’s potential, it is easy to forget that the region is a pharma and biopharma powerhouse and is primed for further growth, if BioMarin is any barometer.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited